The American Journal of Managed Care: AI Matches Physician Accuracy in Insulin Dosing for T2D Artificial intelligence (AI) can match physician insulin dosing, maintaining target blood sugar levels in patients with type 2 diabetes. A study showed an AI-based insulin decision support system's ... The FDA has approved Awiqli, the first once‑weekly long‑acting basal insulin, for adults with type 2 diabetes, which offers convenient weekly dosing compared with daily basal insulin injections.
FierceBiotech: Glooko adds insulin dosing recommendations to diabetes management app with Hedia collab Glooko adds insulin dosing recommendations to diabetes management app with Hedia collab The American Journal of Managed Care: FDA Panel Supports Using CGM for Insulin Dosing The US Food and Drug Administration has cleared new decision-support software that aids in insulin dosing. In addition, Insulin Algorithms is "an affordable, easily adoptable tool for every-size ... Indianapolis-based pharma company Eli Lilly recently recieved FDA 510K clearance for a new mobile app called Go Dose, a diabetes management and insulin dosing app for users of Humalog, Lilly's ...
